MC

M28 Capital

North America, Connecticut, United States, Greenwich

Description

M28 Capital is a healthcare sector fund that hopes to generate investment returns from the ongoing biotechnology.

Investor Profile

M28 Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Therapeutics.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does M28 Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
Adimab
North America, New Hampshire, United States, Lebanon
Co-Investments: 1
Mithril Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by M28 Capital?

Invivyd

Waltham, Massachusetts, United States

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

BiotechnologyPharmaceuticalTherapeutics
Series AJul 16, 2020
Amount Raised: $50,000,000